Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter-still a dilemma?

Monika E. Hegi*, Roger Stupp

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

40 Scopus citations

Fingerprint Dive into the research topics of 'Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter-still a dilemma?'. Together they form a unique fingerprint.